Critical Ill Patients, Ventilated Patients
Conditions
Keywords
Full closed-loop ventilation control, Critical care
Brief summary
Nursing is essential in critically ill patients care but with high risk of hypoxia, especially during mobilization. Full closed-loop control ventilation is well established for her safety in unselected ventilated critical care patients with different lung conditions compared to conventional ventilation. The aim of this study is to assess the ability of a full closed-loop control ventilation (Intellivent-ASV, TM) to reduce hypoxia during mobilization period in unselected ventilated patients.
Detailed description
Prospective randomized cross over study including all consecutive ventilated patient with predicted duration of ventilation \> 48 hours, inspired oxygen fraction \< 60% and without neuromuscular blocking agent. Patient were randomized to be ventilated with full closed-loop control or conventional ventilation 30 minutes before the first nursing period after inclusion. The ventilator was switched in the other mode (conventional or full closed-loop respectively), 30 minutes before the following nursing period. Between this two consecutive nursing periods, ventilation mode is choosed by the attending physician. The primary outcome was the oxygenation measured by pulse oxymetry during the nursing periods.
Interventions
Sponsors
Study design
Intervention model description
Prospective randomized crossover study
Eligibility
Inclusion criteria
* Invasive mechanical ventilation for expected time \>48h
Exclusion criteria
* Pregnancy * Neuromuscular blocking agent (discontinuous or continuous) infusion * Inspired oxygen fraction (FiO2) setting \> or = 60% * Mobilization contraindication (hemodynamic instability, unstable vertebral trauma, etc.) * Neurological breathing (patients with brain injury) * Pulse oxymetry monitoring unavailable * Expected ventilation weaning \<24h after randomization. * Moribund patients
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Time spent with SpO2 values > 90 and < 95% | 1 day | Pulse oxymetry monitoring |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Time spent with SpO2 values < or = 90% | 1 day | Pulse oxymetry monitoring |
| Time spent with SpO2 values > or = 95% | 1 day | Pulse oxymetry monitoring |
Countries
France